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Background: Cardiomyopathy syndrome (CMS) is a severe disease of Atlantic salmon (Salmo salar L.) associated
with significant economic losses in the aquaculture industry. CMS is diagnosed with a severe inflammation and
degradation of myocardial tissue caused by a double-stranded RNA virus named piscine myocarditis virus (PMCV),
with structural similarities to the Totiviridae family. In the present study we characterized individual host responses
and genomic determinants of different disease outcomes.
Results: From time course studies of experimentally infected Atlantic salmon post-smolts, fish exhibited different
outcomes of infection and disease. High responder (HR) fish were characterized with sustained and increased viral
load and pathology in heart tissue. Low responder (LR) fish showed declining viral load from 6–10 weeks post
infection (wpi) and absence of pathology. Global gene expression (SIQ2.0 oligonucleotide microarray) in HR and LR
hearts during infection was compared, in order to characterize differences in the host response and to identify
genes with expression patterns that could explain or predict the different outcomes of disease. Virus-responsive
genes involved in early antiviral and innate immune responses were upregulated equally in LR and HR at the first
stage (2–4 wpi), reflecting the initial increase in virus replication. Repression of heart muscle development was
identified by gene ontology enrichment analyses, indicating the early onset of pathology. By six weeks both
responder groups had comparable viral load, while increased pathology was observed in HR fish. This was reflected
by induced expression of genes implicated in apoptosis and cell death mechanisms, presumably related to
lymphocyte regulation and survival. In contrast, LR fish showed earlier activation of NK cell-mediated cytotoxicity
and NOD-like receptor signaling pathways. At the late stage of infection, increased pathology and viral load in HR
was accompanied by a broad activation of genes involved in adaptive immunity and particularly T cell responses,
probably reflecting the increased infiltration and homing of virus-specific T cells to the infected heart. This was in
sharp contrast to LR fish, where recovery and reduced viral load was associated with a significantly reduced
transcription of adaptive immunity genes and activation of genes involved in energy metabolism.
Conclusions: In contrast to LR, a stronger and sustained expression of genes involved in adaptive immune
responses in heart tissue of HR at the late stage of disease probably reflected the increased lymphocyte infiltration
and pathological outcome. In addition to controlled adaptive immunity and activation of genes involved in cardiac
energy metabolism in LR at the late stage, recovery of this group could also be related to an earlier activation of
NOD-like receptor signaling and NK cell-mediated cytotoxicity pathways.* Correspondence: sven.jorgensen@nofima.no
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Cardiomyopathy syndrome (CMS) is a severe cardiac dis-
ease affecting farmed Atlantic salmon (Salmo salar L.) pri-
marily in the second year in seawater close to harvest
[1,2]. Since the first diagnosis in Norway in 1985 [3], it has
later been diagnosed in Scotland, the Faroe Island, Den-
mark and Canada [1,4-6]. Pathology associated with CMS
has also been observed in wild Atlantic salmon [7]. CMS
is diagnosed based on cardiac histopathology, charac-
terised by a severe inflammation and necrosis of the
spongy myocardium of the atrium and ventricle [4]. In-
flammatory infiltrates consist of mononuclear cells, prob-
ably lymphocytes and macrophages. The compact layer of
the ventricle is usually less affected, and always occurs
later than changes in the spongious layer [4,8]. Farmed
salmon suffering from CMS often lack clinical signs and
may die suddenly due to rupture of the atrium or sinus
venosus resulting in cardiac tamponade [3,4]. A remark-
able feature of CMS is the slow development of pathology,
which is observed both in the field and under experimen-
tal conditions [8-10].
Recently, the causative agent of CMS was identified as
double-stranded RNA virus with the proposed name pis-
cine myocarditis virus (PMCV) [9]. The same virus se-
quence was also identified from high-throughput
sequencing of fish with CMS [11]. PMCV has a genome
size of 6,688 bp with three open reading frames, the sec-
ond encoding an RNA-dependent RNA polymerase
showing sequence similarities with Giardia lamblia virus
and infectious myonecrosis virus of penaeid shrimp, sug-
gesting assignment to the Totiviridae family [9]. Follow-
ing experimental challenge with cell culture-grown virus,
histopathological changes were observed in heart tissue
from 6 weeks post-infection (wpi) with peak severity at
9–10 wpi [9,10]. Analysis of viral load by quantitative
real-time RT-PCR (qPCR) showed replication of virus in
several organs from 4 wpi, suggesting a broad tissue
tropism. Peak of viral load occurred in heart, spleen and
kidney and coincided with the peak of cardiac pathology
[10]. Viral load in the hearts from experimental and clin-
ical field cases correlated well the severity of histopatho-
logical changes, suggesting that cytopathic effects of
infection was a major determinant of the myocardial
changes [9,10]. From transcriptome analysis of immune
responses in fish, developing the strongest pathology
and infection, the temporal and spatial regulation of the
different arms of immunity during CMS was charac-
terised [10]. It was shown that the peak of cardiac path-
ology and viral load coincided with a cardiac-specific
induction of T cell response genes and splenic induction
of complement genes. Activation of these responses was
preceding a reduction in viral load and pathology, sug-
gesting that they were important for viral clearance and
recovery.From the same challenge experiment, a significant pro-
portion of the infected fish did not develop cardiac path-
ology, providing an opportunity for a comparative study of
individuals with different outcomes of disease and charac-
terisation of the underlying molecular mechanisms asso-
ciated with protection versus pathology. Here, we use
transcriptome analysis to show that fish developing sus-
tained or increased viral load and severe pathology (so
called high responders, HR) have a different character and
regulation of immune responses and metabolic pathways
compared to fish with viral clearance and absence of path-
ology (so called low responders, LR). These results provide
a novel understanding of individual responses to CMS
and genomic and immunological correlates of virus clear-
ance, recovery and pathology.
Results
PMCV infection and disease responders
From a challenge trial where fish were infected with
intraperitoneal (IP) injection of identical doses of PMCV
[10], we observed different outcomes of cardiac path-
ology between individuals. It was shown that all fish
mounted a similar antiviral status (gene expression,
microarrays/qPCR) and cardiac viral load (PMCV RNA,
qPCR) until 6 weeks post infection (wpi). At this time
point, cardiac pathology associated with CMS (histo-
pathology score 2) was first significant and found positive
in 17/27 fish. In the present study, we quantified viral load
in an extended number of individuals (n= 10–15 per time
point) and found that in the subsequent course of infec-
tion (8–10 wpi), fish could be divided in two groups
according to differences in the development of disease
(histopathology) and infection (viral load) (Figure 1). One
group, termed high responders (HR), developed sustained
or increased PMCV levels in heart together with elevated
pathology that further decreased until 12 wpi [10]. In the
other group, termed low responders (LR), viral load
declined from 6–10 wpi to levels similar as for fish at 2
wpi, and no pathology was detected. According to these
observations, we compared global gene expression in
hearts of HR and LR during infection, in order to
characterize potential differences in the host response and
to identify gene expression patterns that could explain or
predict the different disease outcomes.
Overall host responses in high and low responders
As a basis for gene expression analysis, the entire time
course of disease was divided into three stages according to
the characteristics of infection and pathology for HR and
LR (Figure 1): the early stage (2–4 wpi) with equal viral load
and histopathology score (before separation of HR/LR), the
mid stage (6 wpi) with equal viral load but different histo-
pathology score, and the late stage (8–10 wpi) where both
viral load and histopathology were different between HR
Figure 1 Virus load and pathology of disease responders. PMCV RNA level and pathology score in heart tissue of challenged fish over the
time course of infection. The three stages of disease (early = 2–4 wpi, mid = 6 wpi and late = 8–10 wpi) are indicated on top of the figure, as
explained in Results. Relative quantification of PMCV by qPCR is given as fold change of viral transcripts relative to the median levels of 0 wpi
samples set to 1. Individual values are shown as dots and colored according to the level of CMS pathology (histopathology score level based on
atrium; green= score 0, yellow= 1, orange= 2, red = 3). Significant differences in viral load between high responder fish (HR, orange and red dots)
and low responder fish (LR, green and yellow dots) from mid and late stages are marked with asterisks (t-test on log-transformed values,
p< 0.01). Overlapping dots were plotted beside each other.
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from each stage is given in Additional file 1. Microarrays
analysis was performed on 32 control (sham-injected) fish
and 33 challenged fish, including 11 fish from the early
stage and 11 HR and 11 LR fish from mid and late stages
(Figure 1). For initial characterization of overall host
responses in HR and LR, differentially expressed genes
(DEG) were subject to enrichment analysis of gene ontol-
ogy (GO) classes and KEGG pathways per each stage and
responder groups (Figure 2). Common responses at the
early stage included activation of innate immune responses;
immune signaling pathways (Toll-like receptors, Jak-STATs,
chemokines), antigen presentation (MHC class I complex)
and processing (proteasome, protein modification- and
ubiquitin-dependent processes), complement and phago-
cytosis. Repressed responses included cellular developmen-
tal processes, cytoskeleton organization and cardiac muscle
development, possibly reflecting the infection-related stress
and initial cellular events of pathological changes. Activa-
tion of immune responses was maintained through the mid
stage for both HR and LR, with a large overlap of immune
categories between the two groups (Figure 2, Additional file
2). However, three pathways were specifically activated in
LR at this stage, namely cytokine-cytokine receptor inter-
action (7 genes), natural killer (NK) cell-mediated cytotox-
icity (8 genes) and NOD-like receptor (NLR) signaling
pathway (5 genes). The two latter pathways were interest-
ing, being important for cell-mediated immune defense
(NK cells) and for the innate cytosolic immune sensing and
priming of antigen-specific T cell immunity (NLR pathway),yet with limited functional understanding in teleost fish. At
the late stage, differences in responses between HR and LR
were most prominent. While the number of upregulated
immune categories increased significantly in HR, these
were completely ablated or leveled off in LR. Instead, LR
fish showed significant induction of different catabolic and
metabolic processes, possibly reflecting responses asso-
ciated with recovery.
Gene markers and predictors of responses and disease
outcome
Further, we identified genes associated with the early re-
sponse to infection and genes with expression differ-
ences between HR and LR in mid and late stages.
Differentially expressed genes with contrasting expres-
sion between HR and LR (t-test, p< 0.05) and expres-
sion profiles that correlated to the early, mid and late
stages of infection were selected (Pearson’s correlation
coefficient> 0.6, Additional file 3). Heat maps of
selected genes are shown in Figures 3, 4 and 5.
Markers of early antiviral response
We identified 250 genes that showed significant upregu-
lation in the early stage and gradually decreased expres-
sion at the mid and late stages (Additional file 3). These
genes were induced with an average log2-ER of +1.7 at
the early stage; expression ratios of 20 genes are shown
in Figure 3 (selected based on functional importance by
evidence from other transcriptome studies in fish or
higher vertebrates). The majority of these genes were
Figure 2 Enrichment analysis of gene ontology classes and pathways. Gene enrichment analysis of regulated gene ontology (GO) classes
and KEGG pathways in all fish at the early disease stage, and in high (HR) and low responder (LR) groups at the mid and late stage. Categories
highlighted in red indicate upregulated genes and blue indicate downregulated genes. Categories that were only regulated in one group (HR or
LR) in mid and late stages are indicated with bold text. The different bioinformatics sources used for analyses are indicated (column “source”); ST:
GO/KEGG: STARS platform, B2GO: BLAST2GO/Cytoscape. Column “#” shows the number of regulated genes behind the respective GO term (see
Additional file 2 for primary data).
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are part of the early antiviral and interferon (IFN) re-
sponse to CMS [10]. Other genes in this group encode
proteins important for protein degradation and antigen
presentation via MHC.
Early pathology and outcome predictors
Since viral clearance occurred in LR at the late stage,
genes that were differentially induced or repressed in LR
versus HR at the preceding mid stage might represent
prognostic markers of disease outcome. Differentially
expressed genes at this stage were of particular interest,since PMCV levels in heart correlated with histopath-
ology score [10] and this was the only stage where HR
and LR had different histopathology score levels but
equal viral loads. Thus, such genes may represent early
predictors of pathology or recovery/clearance. We iden-
tified nine genes (twelve transcripts, including one hypo-
thetical gene) that were induced at mid stage in HR but
not in LR (predictors of early pathology, Figure 4A), and
seven genes (nine transcripts) that were induced in LR
but not in HR (early predictors of recovery/clearance,
Figure 4B). Genes induced in HR were mainly immune-
related by function. Probable ATP-dependent RNA
Figure 3 Gene markers of early antiviral response. Heat map of 20 selected genes with expression profile showing upregulation at the early
stage and gradually decreased expression during mid and late stages of infection (complete data in Additional file 3). Left columns show the
median log2 expression ratios of genes in the different stages and responder groups (“E”= early, “M:HR”=mid stage HR, “M:LR”=mid stage LR, “L:
HR”= late stage HR, “L:LR”= late stage LR). Graded levels from white to red and blue indicate respectively upregulation and downregulation,
according to the color scale (row “L”). Significant differences in log2–ER between control and infected samples (t-test, p< 0.05) are shown in bold.
Column “cat” indicates the category of gene annotation according to [10]: V- early antiviral and IFN response, P- MHC antigen presentation..
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lating many aspects of transcription and shown to inter-
act with HCV replication [13]. The other genes were
implicated in apoptosis and thus might be a part of cellFigure 4 Early pathology and outcome predictor genes. Heat map of a
LR (B) fish at the mid stage of infection. Further explanations are given in F
according to [10]: V- early antiviral and IFN response, T- T cell response, M-
apoptosis, I- implicated in immune response, E- mitochondrial electron cha
name and Refseq ID match, but represent different cDNA sequences on thdeath mechanisms controlling lymphocyte regulation
and survival. TNF decoy receptor (also known as TR6 or
decoy receptor 3), is a member of the TNF receptor
superfamily and an important mediator of T cellll genes with expression profile showing upregulation in HR (A) and
igure 3. Column “cat” indicates the category of gene annotation
muscle cytoskeleton development, L- lymphocyte regulation, A-
in/energy metabolism, O- other/unknown. Genes may have identical
e array (see Additional file 3).
Figure 5 Gene markers of pathology and outcome. Heat map of selected genes with expression profile showing strongest upregulation in HR
(A) or LR (B) fish at the late stage of infection. Further explanations are given in Figure 3. Column “cat” indicates the category of gene annotation
according to [10]: T- T cell response, P- MHC antigen presentation, B- B cell response, A- apoptosis, M- muscle cytoskeleton development, E-
mitochondrial electron chain/energy metabolism, I- implicated in immune response, O- other/unknown.
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(reviewed in [14]). Similarly, GTPase IMAP7 family
member 7 (or IAN7, GIMAP7) is part of a newly discov-
ered family of cell survival regulators expressed in lym-
phocytes [15]. Lymphocyte G0/G1 switch protein 2
(G0S2) was identified as a novel pro-apoptotic factor
induced by TNF-α through NF-κB and shown to
antagonize Bcl-2 [16]. Interestingly, G0S2 expression
was particularly high in heart and peripheral blood cells,
the latter was also observed during measles virus infec-
tion in humans [17]. Yet another HR-induced pro-
apoptotic gene was cell death activator CIDE-3 which
was also specifically expressed in heart and intestine
[18]. Its implication in virus infection has also been
reported [19].Genes that were induced in LR had no clear functional
relation to the disease, except for CD209 antigen-like
protein A and lectin precursor, presumably involved in
immune-cell signaling (Figure 4B).
Markers of pathology and outcome
To identify genes whose expression patterns were predict-
ive of the outcome of infection, we searched for genes that
were induced during declining viral load/pathology at late
stage in LR but not in HR (predictors of recovery/clear-
ance), and genes that were upregulated during increased
viral load/pathology in HR but not in LR (predictors of
pathology). We identified 116 genes that were induced in
HR while 33 genes were induced in LR (Additional file 3).
Nearly all genes with higher expression in HR were
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were included in our previously identified CMS profiles
for T/B cell responses, MHC class I antigen presentation
and apoptosis [10]. Increased migration of leukocytic cells
(e.g. macrophages and dendritic cells) was also evident
from induced gene expression of several chemokines and
cytokines (Additional file 3). Genes related to T cell
responses were overrepresented, which likely reflected
increased infiltration and homing of virus-specific T cells
to the infected tissue. Upregulation of genes encoding
components of the T-cell receptor (CD3gammadelta-A,
CD3 zeta chain precursor and CD28) substantiated this
assumption. In addition, an activator of naïve T cells, SH2
domain-containing protein 1A was induced. Genes with
putative roles in the regulation of effector function and
controlled cell death of T cells included several TNF-
related genes and programmed cell death ligand 1 (aka
CD274/B7-H1). Upregulation of genes encoding Rho
GTPases was also interesting, since they have been impli-
cated in the regulation of T cell-receptor signaling and
cytoskeletal reorganization, cell migration and apoptosis
in T cells [20].
Genes that were induced during declining viral replica-
tion in LR and not in HR encoded for enzymes of meta-
bolic pathways or cell respiration, and can be considered to
represent markers for recovery or protection (Figure 5B).
Some of these enzymes are involved in the intermediate
pathways of metabolism, e.g. aldolase a, triosephosphate
isomerase and phosphoglycerate mutase 2–2 (all involved in
gluconeogenesis and glycolysis), malate dehydrogenase
(catalytic enzyme in the citric acid cycle) and peroxisomal
3,2-trans-enoyl-CoA isomerase (involved in beta-oxidation
of unsaturated fatty acids). Components of the electron
transport chain included ATP synthase (H+ transporting
mitochondrial F1 complex alpha subunit), electron transfer
flavoprotein subunit alpha and succinate-CoA ligase GDP-
forming alpha subunit. Three genes are potentially
involved in heart muscle regeneration. Hydroxysteroid
dehydrogenase-like protein 2 was induced during myocar-
dial injury following injection of bone marrow mono-
nuclear cells in rats [21]. Calsequestrin-like protein is
important for the Ca2+ regulation in muscle cells and a
dramatic decrease of protein concentration was observed
in a proteomics study of human dystrophic muscle fibers
[22]. β-parvin (aka Affixin) is a integrin-linked protein
that is involved in the linkage between integrin and the
cytoskeleton and was supposed to be involved in mem-
brane repair mechanisms in human [23].
To substantiate these results, expression of four genes
were evaluated by qPCR in an extended number of indi-
viduals per group (n = 9 HR, n = 10 LR, 8 wpi). Genes
implicated in T cell responses were tested; TNF decoy re-
ceptor as marker of early pathology, CD274 and TNF-
11b as markers of late pathology, and granzyme A(GzmA) as a marker of cytotoxic T cells and the T cell
response to CMS [10]. As shown in Figure 6, all genes
had significantly higher relative expression ratios in HR
versus LR (t-test on log2-transformed values, p< 0.01).
In contrast to the other genes, GzmA was also upregu-
lated in LR, however significantly lower than in HR.
Taken together, induced transcription of these genes
suggested an increased population and activity of T cells
in infected hearts of HR compared to LR. Next we ana-
lysed differentially expressed GO categories between HR
and LR that were positively or negatively correlated to
the viral load at the late stage (Figure 7). As expected,
positively correlated functional groups in HR included
immune system process/immune response and more
specifically, activation of lymphocytes and leukocytes.
Negatively correlated groups included a large number of
categories related to cardiac and skeletal muscle devel-
opment (Figure 7 and Additional file 4). In LR fish, no
immune-related GO categories showed correlation to
viral load. In contrast, metabolic processes, generation
of precursor metabolites/energy and oxidation reduction
were positively correlated categories, while muscle cell
development and skeletal myofibril assembly were nega-
tively correlated.
Microarray confirmation by qPCR
To validate microarray data, log2-transformed expression
levels of four early antiviral genes by qPCR were com-
pared with the respective expression ratios from micro-
arrays (Figure 8). Primers for qPCR (Additional file 5)
and oligonucleotide probes on the microarray were
based on the same cDNA sequences. Data from eight
infected fish showed high correlation between the two
methods.
Discussion
In this study, we compared the host response in PMCV
infected salmon with different outcomes of disease in order
to characterize gene expression patterns and responses that
could be associated with cardiac pathology versus recovery.
Assessment of viral load and histopathology from bi-weekly
samples of heart over a period of ten weeks suggested that
fish exhibited different development of disease from six
weeks post-infection. The so called high responders (HR)
group developed severe pathology and increased infection
level while the low responder (LR) group showed reduced
viral load and retained a normal heart with absence of ele-
vated pathology. This could be interpreted as different re-
sistance to the disease since all fish were simultaneously
infected using a standardized IP-injection with identi-
cal dose of virus. Previous analyses of fish from the
same challenge trial also showed that all fish (n = 20)
mounted a similar level of early antiviral response
[10]. The early stage (2–4 wpi), was characterized by
Figure 6 Gene expression of selected markers of late pathology. Real-time qPCR expression of four genes identified as pathology markers
from microarrays in an extended number of individuals eight weeks post-infection. Gene abbreviations are; tnf-11b: tumor necrosis factor receptor
superfamily member 11b, cd274: programmed cell death ligand 1, gzmA: granzyme A, tnf-d: tumor necrosis factor decoy receptor. The gene expression
ratios are shown as boxplots based on nine HR fish (red) and ten LR fish (green) against the average of control fish. Values of the fish used in the
microarray experiments are highlighted with dots and colored according to their histopathology score level (see Figure 1). Boxes represent 50%
of the values, while black bars mark the median log-ER. Whiskers indicate the maximum length of 1.5 times the box length. Significance levels
between all HR and LR fish are indicated on top of the plot (t-test on log-transformed values, ** = p< 0.01).
Figure 7 Gene ontology classes correlated to viral load at late stage. Gene ontology classes correlated to viral load in responder groups at
the late stage of infection. Significantly enriched GO classes (FDR correction, p< 0.05) with positive or negative correlation to viral load (Pearson’s
r> 0.6) in HR and LR groups at 8–10 wpi are shown. Column “#” shows the number of genes behind the respective GO term/class, and only the
ten GOs with lowest p-values are shown (for completed data, see Additional file 4)..
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Figure 8 Confirmation of microarray results by qPCR. Comparison of gene expression results obtained with qPCR and microarrays. Log2-ER of
four genes were compared (n = 8, plotted as letters; a = radical s-adenosyl methionine domain-containing protein 2 (rsad2/viperin), b = interferon-
induced protein with tetratricopeptide repeats 5 (ifit 5), c = retinoic acid inducible gene I (rigI), d = barrier to autointegration factor (baf)). The dashed
black line represents the regression function of the measured values. The regression model, correlation coefficient and p-value are shown in the
graph.
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myocardial tissue (histology score 0–1). However, results
of enrichment analysis of GO classes and KEGG pathways
showed repression of many functional groups related to
cardiac and general muscle development, suggesting an
onset of pathology at the molecular/cellular level. This
could also be expected, given the strong antiviral response
(at transcriptome level) in the cells at this stage, possibly
leading to compromised cell growth. Both pathway ana-
lysis and gene expression profiling suggested that the early
antiviral response involved genes of the interferon path-
way and antigen presentation pathways via MHC, as was
observed in our recent study [10]. Most of these genes
were identified as virus-responsive with high correlation
to expression of the salmon IFNa gene [12]. These are typ-
ical early responses to viruses and reflect the innate im-
mune response followed by initiation of the adaptive
immune response [24,25]. Thus, our results show that
PMCV-infected cells successfully induced the transcrip-
tion of many antiviral and IFN-dependent genes, but that
this response had little or no direct effect on virus replica-
tion and outcome, since their magnitude of expression
was negatively correlated with development of infection/
disease and their expression remained induced within the
whole challenge trial, except for the late stage in LR which
had lowest viral loads. The same was observed in a studywith viral haemorrhagic septicaemia virus infected rain-
bow trout, where genes of the interferon system were cor-
related to the viral load in affected tissue, however strong
expression did not reflect a better protection against virus
spread [26]. Nonetheless, these innate antiviral responses
play a pivotal role in the activation of downstream adap-
tive immunity.
The mid stage of the disease was characterized by
similar viral loads but different histopathology score in
LR and HR. Pathway analysis showed a similar activation
of most immune categories except for the LR-specific in-
duction of NK cell-mediated cytotoxicity and NLR sig-
naling pathways. These pathways were not induced at
the early stage, but were later activated also in HR (late
stage, 8–10 wpi). Despite a limited functional under-
standing of these responses in fish, they have important
roles in the border between innate and adaptive immun-
ity [27]. The earlier activation of NLR signaling (LR) in
addition to the activation of Toll-like receptor pathway
(LR and HR), may indicate a broader repertoire of virus-
associated molecular pattern recognition in LR. For the
analysis of predictor genes, our main hypotheses were that
genes with stronger expression in HR than in LR repre-
sent predictors of early pathology, and genes with stronger
expression in LR than in HR might represent predictors of
protection/recovery. The predicted functional role of the
Timmerhaus et al. BMC Genomics 2012, 13:205 Page 10 of 14
http://www.biomedcentral.com/1471-2164/13/205majority of genes with significantly higher expression in
HR (Figure 4) were interesting in view of the development
of pathology in the subsequent late stage, which in our
previous study was characterized by an increased inflam-
mation dominated by influx of T cells [10]. In mammals,
these genes are involved in cell death mechanisms and
have been implicated in the control of lymphocyte regula-
tion and survival. Induced transcription of these genes at
mid stage of CMS in HR was likely a result of the initial
rise in lymphocyte infiltration to the infected tissue as
reflected from histopathology (this was the first stage with
score 2, representing pathology above normal background
levels, score 0/1). Since predictor genes were identified
based on expression differences between HR versus LR,
potential genes with equal expression in HR/LR at this
stage were not taken into account. In this respect it is ne-
cessary to mention that many genes related to the T cell
response in CMS [10] were upregulated already at the mid
stage (see Figure 5 and Additional file 3), however differ-
ences between HR and LR appeared later. Thus, activation
of lymphocytic and inflammatory responses occurred in
both responder groups, but different abilities to control or
regulate these responses might explain different outcomes
in the subsequent stage. The importance of these
responses in immunity versus immunopathology is inten-
sively studied in human infections [28], and should de-
serve more attention in relation to viral infections in fish.
The recent studies on CMS showed a high correlation
between histopathology score and viral load implying that
the cytopathic effect of infection was a major determinant
of the myocardial changes [9,10]. Results of this study fur-
ther show that the level of pathology and infection is cor-
related to the activation of lymphocytes and leukocytes
and particularly expression of genes associated with the T
cell response at the late stage in HR. This was also
expected, assuming that this response reflects the migra-
tion of virus-specific lymphocytes to the infected tissue.
Infiltration of leukocytes/lymphocytes did not occur in LR
fish according to histopathology results. This was accom-
panied by a completely absent expression of a large num-
ber of genes mainly related to T and B cell responses in
the late stage, which was the most significant difference
between HR and LR fish identified in this study. The lack
of transcription of many genes involved in the regulation
of T cell effector function and cell death/survival was of
particular interest. Control of these processes is funda-
mental for regulation of the T cell response and for main-
taining homeostasis in the immune system after it has
expanded to combat infections [28,29]. As already dis-
cussed, many of these genes were also expressed at the
mid stage of HR but not in LR. Elevated gene expression
levels of granzyme A (gzmA) in LR fish showed that cyto-
toxic cells were also present in the heart of these fish.
GzmA is a serine protease and important inducer ofantiviral and apoptotic pathways in infected cells, pro-
duced by cytotoxic T cells and NK cells [30]. This suggests
that adaptive cellular immune responses occurred in LR
fish as well, however on a lower level compared to HR
fish. Hence, both different shaping and a lower magnitude
of immune responses could explain the different outcome
of these groups. In contrast to HR, genes involved in en-
ergy metabolism and other catabolic/metabolic processes
were induced in LR. In addition, the GO enrichment ana-
lysis showed that the same processes were correlated to
the decline in viral load in LR. Thus, in contrast to HR,
these fish seemed to cope with the infection by immune
responses in the preceding stages and/or by a different
composition or regulation of the late response, and mana-
ged to activate cardiac energy metabolism for recovery
and regeneration of infected tissue in the late stage.
Conclusion
We have compared the host response and pathogen-
esis in PMCV infected salmon with different outcome
of disease, and described gene expression patterns
and predictors and associated functional pathways
underlying these differences. The main findings are
summarized in Figure 9, suggesting that very different
composition and regulation of adaptive cellular im-
munity in the late stage of infection was the most
prominent feature associated with pathology versus
recovery. In our previous CMS study focusing on the
most severely diseased fish, we also concluded that
the same responses were possibly associated with an
observed viral clearance and reduced pathology later
on (10–12 weeks post infection) [10]. Consequently,
while having an important role in the clearance of
virus in infected heart tissue, virus-specific immune
cells such as T and B cells may at the same time lead
to increased tissue damage and burden for the host.
Whether the stronger immune responses observed in
HR was reflecting an immunopathology could not be
concluded based upon the present data. However, the
importance of understanding the balance between im-
munity and immunopathology is highly acknowledged
in human disease [28], and should be subject to fur-
ther study in viral diseases of Atlantic salmon. The
basis for the positive outcome of LR fish is also not
known. A recent field study with family group indi-
cated a genetic basis for survival against CMS (N.
Santi, personal communication). Fish used in the present
study were from a commercial standard Norwegian strain
with mixed genetic background. Thus, it could not be
ruled out that the observed differences in disease response
were influenced by genetic background. Effects of genetic
background on disease development and host responses
in controlled infection trials will be subject to future
research.
Figure 9 Summary of pathogenesis in responder groups. Summary of host-virus responses in high and low responder fish based on findings
from a previous CMS study [10] and the present work, as indicated with superscript letters a and b, respectively. Colored circles in fish illustrate
histopathology (atrium score level), analogous to Figure 1.
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Experimental infection and sampling
The biological material for this work was taken from a
challenge trial previously described in [10]. In this trial,
120 fish were kept in four separated tanks; one infected
and one control group in duplicates. The fish had an
average weight of 50 gram at start. Each fish of the
infected group received an IP-injection dose (0.2 ml) of
an inoculate originating from a passaged cell culture
developing cytopathogenic effects after infection with fil-
tered heart homogenate derived from several adult
Atlantic salmon with clinical CMS. Control groups
received the same dose of conditioned cell culture
medium. Tissue samples were collected 2, 4, 6, 8 and 10
wpi. At each sampling date, 15 fish from each of the four
tanks were sedated (as described above) and euthanized
by decapitation. For this study standardised samples from
heart were snap-frozen in liquid nitrogen for RNA and
fixed in formalin (10% neutral phosphate-buffered) for
histology.
Histopathology
Scoring of heart lesions by histopathological examin-
ation was taken from a previous study as described
[10]. In brief, score 0 and 1 was considered normal,
with no histopathological findings (score 0), or a sin-
gle or few focal lesions (score 1). Score 2 represented
several distinct lesions and increased mononuclearinfiltration. Score 3 represented multifocal to conflu-
ent lesions in> 50% of tissue and moderate to severe
leukocyte infiltration. Histopathology of individual fish
shown in Figure 1 is based on histoscores from
atrium.
RNA extraction
Sampled hearts for microarray hybridization were stored
at −80°C prior to RNA extraction. Standardised tissue
sections of 10 mg (equal mix of ventricle and atrium)
were prepared under sterile/RNase-free conditions and
transferred directly to 1 ml chilled TRIzol (Invitrogen,
Carlsbad, CA, USA) in 2 ml tubes with screw caps
(PrecellysW24, Bertin Technologies, Orléans, France). Two
steel beads (diameter: 2 mm) were added to each tube
and the tissue was homogenized in a PrecellysW24
homogenizer for two times 25 sec at 5000 rounds per
minute with a break of 5 sec between the rounds.
RNA was extracted from the homogenized tissues
using PureLink RNA Mini kits according to the
protocol for TRIzol-homogenised samples (Invitrogen).
The concentration of extracted total RNA was measured
with a NanoDrop 1000 Spectrometer (Thermo Scientific,
Waltham, MA, USA). The integrity of total RNA was esti-
mated, using an Agilent 2100 Bioanalyzer with RNA Nano
kits (Agilent Technologies, Santa Clara, CA, USA). Only
samples with RNA integrity number (RIN) of 8 or higher
were accepted.
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Experiments were conducted according to the MIQE
guidelines [31]. Synthesis of cDNA was performed on
0.2 μg DNAse-treated total RNA (Turbo DNA-freeTM,
Ambion, Austin, TX, USA) using the TaqManW Gold
Reverse Transcription kit (Applied Biosystems, Foster
City, CA, USA) in 25 μl reactions with random hexamer
priming according to manufacturer’s protocol. Comple-
mentary DNA was stored undiluted at −80°C in aliquots
to avoid repeated freeze-thawing. To avoid risk for pres-
ence of residual DNA contamination, control reactions
without RT was tested and qPCR primers were possibly
designed to span introns. Oligonucleotide primers for
genes of Atlantic salmon were designed with the program
eprimer3 from the EMBOSS program package (version
5.0.0, http://emboss.sourceforge.net/). Amplicon size was
set to 80–200 and melting temperature to 59–61°C.
Primers were purchased from Invitrogen (Additional
file 5). In silico analysis of gene targets was performed
using a customised program for BLAST and sequence
alignments [12]. PCR amplicon size and specificity were
confirmed by gel electrophoresis and melting curve ana-
lysis (Tm calling; LightCyclerW 480, Roche Diagnostics,
Mannheim, Germany). QPCR was conducted in duplicate
reactions as described [10]. Cycle threshold (CT) values
were calculated using the second derivative method. Du-
plicate measurements that differed more than 0.5 CT
values were removed and reanalysed. For relative quantifi-
cation, the mean of duplicates was used. Relative expres-
sion ratios of test samples versus the average of the
controls were calculated according to the Pfaffl method
[32]. Elongation factor 1α (GenBank ID: BT072490.1) was
used as reference gene [33], and was found to be stably
transcribed in control and test samples according to the
BestKeeper software [34]. The efficiency of the PCR reac-
tions was estimated for all primer pairs by six times 1:5 di-
lution series of a cDNA mix of all used samples. The
efficiency values were estimated by using the LightCyclerW
480 Software (version 1.5.0.39).
Viral load
Relative quantification of PMCV was assessed by
qPCR as described [10]. In brief, total RNA (62.5 ng
per sample, prepared as described above) from
infected fish (heart; weeks 0, 2, 4, 6, 8, 10, n = 5–8
per time point) were subject to cDNA synthesis
(SuperScriptW III PlatinumW Two-Step qRT-PCR Kit
with SYBRW Green, Invitrogen) and qPCR (2X Plati-
numW SYBRW Green qPCR SuperMix-UDG, Invitro-
gen) in triplicate reactions. Melting curve analysis was
performed to confirm expected amplicon. Viral load
was expressed as the relative copy number with non-
infected controls (0 wpi) set to 1 and calculated by
the formula 2^(CT(0wpi median)- CT(sample)).Design of microarray experiments
An overview of microarray hybridizations is shown in
Additional file 1. The salmonid oligonucleotide micro-
array (SIQ2.0, NCBI GEO platform GPL10679) was used
[12], consisting of 21 K features printed in duplicates on
4 x 44 K chips from Agilent Technologies. Two-color
hybridizations in a reference design were used, where
test samples labelled with Cy5 dye and reference samples
labelled with Cy3 dye were competitively hybridized per
array. As reference sample, pools of equimolar amounts
of RNA from heart tissue from 6–8 control fish per time
point were used (only fish with histopathology score 0
were included). The examined time points were 2, 4, 6, 8
and 10 wpi. For each time point, 5–8 individuals from
both test (high and low responders) and control groups
were hybridized against the reference sample, giving a
total number of 65 arrays with 32 control (sham-
injected) individuals and 33 infected (11 from the early
stage, plus 11 HR and 11 LR from mid and late stages).
HR and LR fish (mid and late stage) were identified
based on histopathology score and infection level (viral
load). From each time point representing these stages, 4
HR and LR fish were selected for microarrays except for
6 wpi, where one LR fish were excluded due to low viral
load. From the early stage (2 and 4 wpi, before develop-
ment of significant histopathology) all fish had equal
viral load as previously identified [10], and 5–6 fish per
each time point were randomly selected for microarrays.
Microarray hybridization and data analysis
Unless specified otherwise, all reagents and equipment
used for microarray analyses were purchased from Agilent
Technologies and used according to manufacturer’s
protocol. In brief, RNA labelling and amplification was
performed with Low Input Quick Amp Labeling Kits,
Two-Color and RNA Spike-In Kits, Two-Color for 4 x
44 K microarrays, using 200 ng of total RNA per reaction.
For fragmentation of the labelled RNA, Gene Expression
Hybridization Kits were used. Labelled RNA was hybri-
dized for 17 hours (hybridization oven, Agilent) at 65°C
and rotation speed of 10 rounds per minute. Arrays were
washed for one minute with Gene Expression Wash
Buffer I at room temperature, and one minute with Gene
Expression Wash Buffer II at 37°C. Slides were scanned
immediately after washing using a GenePix Personal
4100A scanner (Molecular Devices, Sunnyvale, CA, USA)
at 5 μm. The laser power was manually adjusted to ensure
an overall intensity ratio close to unity between Cy3 and
Cy5 channels and with minimal saturation of features.
The GenePix Pro software (version 6.1) was used for spot-
grid alignment, feature extraction of fluorescence intensity
values and assessment of spot quality.
Subsequent data processing and analyses were per-
formed using the STARS platform [12]. Values of replicate
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normalization of log2-expression ratios (ER) was per-
formed. Initial quality filtering was based on mean spot in-
tensity and number of informative spots, resulting in
11,913 passed features. Outliers among control fish identi-
fied by cluster analysis (uncentered correlation, complete
linkage using “Cluster 3.0” [35]) were removed. Significant
differences between gene expression of infected and con-
trol fish were calculated by t-tests for each time point and
group (HR and LR). The median values of respective con-
trol fish were subtracted from the individual values of the
infected fish, and median log2-ER for each gene were cal-
culated per group and time point. The final list of differen-
tially expressed genes (DEG) was selected by filtering for
previously mentioned t-tests (p< 0.05, at least one time
point or group) and log2-ER> |0.7| (in at least one time
point or group). Corrections for false discovery rate were
not employed as previous microarray studies with Atlantic
salmon have demonstrated them to be overly conservative
[36,37]. Data was submitted to GEO (accession number
GSE36860).
For identification of marker/predictor genes in HR
and LR, correlation analysis was performed to search for
(i) genes associated with the early antiviral response
(strong induction at the early stage, moderate induction
at the mid stage and late stage HR and no induction at
late stage LR), (ii) genes with expression changes in mid
and late stage HR and LR (iii) genes that were induced
at only one stage and (iv) genes whose expression pro-
files correlated with virus loads. Equal thresholds were
established for all correlations (Pearson’s r> 0.6).
Enrichment of GO classes and KEGG pathways among
DEG were assessed with STARS (p< 0.05, Yates’ corrected
chi square); terms represented with less than five genes were
not taken into consideration. In addition, BLAST2GO [38]
with an E-value cut-off for the BLAST searches of 10-20 was
used for annotations and BiNGO plugin (Version 2.44, [39])
for Cytoscape (http://www.cytoscape.org/, version 2.8.0) for
GO enrichment analyses. Only GO terms with the category
“biological process” were considered and threshold of sig-
nificance of the corrected p-value was< 0.05 (Benjamin &
Hochberg false discovery rate correction). Multiple hits of
identical probes were reduced to the GO term with highest
occurrence (for complete lists, see Additional file 2). Part of
plots and statistical calculations were made with the R soft-
ware package (version 2.13.0, www.cran.r-project.org/).
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Additional file 1: Experimental outline. Overview of experimental
groups and number of biological replicates used for the different
analyses.
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